Publication | Closed Access

Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent

OncologySelective Cox-2 InhibitorHealth SciencesColonic DeliveryMedicineColorectal CancerPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyPotential Pharmaceutical StrategyDrug DiscoveryDrug Resistance